Metabolic Research Peptides · 20mg vial
Tesamorelin
Buy 3+, save 10% · Kit of 10, save 25%
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been studied for its ability to stimulate pulsatile GH secretion and reduce visceral adipose tissue in preclinical and clinical models.
Research has investigated Tesamorelin for its metabolic effects including visceral fat reduction, improvements in lipid profiles, and IGF-1 modulation. It is distinguished from other GHRH analogues by its specific adipose-targeting profile and longer half-life relative to native GHRH. This 20mg vial is suited for extended research protocols.
Composition & Purity
Tesamorelin, Lyophilized powder
For research purposes only
Compound: Tesamorelin — trans-3-hexenoic acid modified GHRH(1-44) analogue
CAS: 218899-48-5
Concentration: 20mg lyophilized powder
Purity: ≥99.7% (HPLC verified)
Storage: Refrigerate at 2–8°C. Protect from light. Reconstitute with bacteriostatic water prior to use.
COA: Available on request.
- Size
- 20mg vial
- Weight
- 20mg
Composition & Purity
Tesamorelin, Lyophilized powder
Suggested research dose: 1–2mg per injection. Consult published literature for specific protocol parameters. For research purposes only.
For research purposes only. Not for human or veterinary use.